NICE quality standards or clinical guidelines | Search results

Showing 1591 to 1596 of 1596 results for nice quality standards or clinical guidelines

Sort by

NICE glossary
The NICE glossary provides brief definitions and explanations of terms used on the website. The terms describe how NICE works and how its guidance is produced.
Anhydrous sodium thiosulfate (Pedmarqsi) for preventing ototoxicity caused by cisplatin chemotherapy in people aged 1 month to 17 years with localised solid tumours [ID1001]
In development [GID-TA10611] Expected publication date: TBC
Result type
Technology appraisal guidance
Status
In development
Kidney Cancer
In development [GID-QS10186] Expected publication date: TBC
Result type
Quality standard
Status
In development
Osimertinib with pemetrexed and platinum-based chemotherapy for untreated EGFR mutation-positive advanced non-small-cell lung cancer [ID6328]
In development [GID-TA11408] Expected publication date: TBC
Result type
Technology appraisal guidance
Status
In development
Vadadustat for treating symptomatic anaemia in adults having dialysis for chronic kidney disease [ID3821]
In development [GID-TA10877] Expected publication date: 20 November 2024
Result type
Technology appraisal guidance
Status
In development
NICE
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.